News|Articles|April 25, 2008

Biovail receives approval for Aplenzin for depression

Aplenzin is a new drug from Biovail Corp. that has been approved to treat depression in adults

Aplenzin (bupropion hydrobromide), formerly known as BVF-033, is an antidepressant from Biovail Corp. that has just received approval from the Food & Drug Administration. The

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.


Latest CME